Floatz logo

Tenecteplase

Basilar Artery Occlusion

Xuanwu Hospital, Beijingprotein_peptidePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Basilar Artery Occlusion cohort.

Asset / SponsorPhaseRating
Recombinant Human Plasminogen Activator
The First Affiliated Hospital of University of Science and Technology of China
Phase 3BB
Arestin
Xijing Hospital
Phase 4BB
Cerebrolysin
University Hospital Sestre Milosrdnice
Early Phase 1C
Unfractionated Heparin
Sunnybrook Health Sciences Centre
N/AD
Acetylsalicylic Acid
Sunnybrook Health Sciences Centre
N/AD

Same molecule, other indications

Tenecteplase is also rated in:

ischemic strokeDormant
BBB
Indicative ·
72 / 100
View asset →
stroke disorderDormant
BBB
Indicative ·
72 / 100
View asset →
ThrombolysisDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →